![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » IN VERITAS ANNOUNCES NEW PATENT FILING
IN VERITAS ANNOUNCES NEW PATENT FILING
August 17, 2006
In Veritas Medical Diagnostics, a firm that designs and develops testing devices, Aug. 17 announced it has filed a patent for a low-cost diagnostic technology that could be used to detect a range of diseases and conditions.
The firm expects the technology to be used for over-the-counter pregnancy and ovulation testing, and as a screening tool for diseases such as HIV or substances such as drugs or alcohol.
The company uses its products to test for chronic conditions affecting large populations. It is currently developing a device for measuring the coagulation of blood in patients with cardiovascular disorders and another product to predict the onset of human labor up to several weeks before birth.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct